Skip to content

IQVIA IQV Derivative assets

Derivative assets at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$4.2B+8.4%
Gross profit$1.4B+4.4%
Operating income$514.0M+3.6%
Net income$274.0M+10.0%
EPS (diluted)$1.61+15.0%

Balance sheet

See full
Cash & equivalents$1.9B+11.9%
Total debt$16.1B+10.7%
Total equity$6.2B+4.1%
Total assets$29.7B+8.6%

Cash flow

See full
Operating cash flow$618.0M+8.8%
CapEx$127.0M-10.6%
Free cash flow$491.0M+15.3%

Valuation

See full
Market cap$32.25B+26.3%
Enterprise value$46.37B+18.6%
P/E23.3×+2.6×
P/S1.9×+0.3×

Profitability

See full
Gross margin33%-1.7pp
Operating margin13.2%-0.9pp
Net margin8.3%-0.3pp
FCF margin12.7%-1.2pp

Returns & leverage

See full
Return on equity22.7%+1.1pp
Debt / equity2.6×+0.2×
Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's derivative assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IQVIA's derivative assets?
IQVIA (IQV) reported derivative assets of $0 in Q1 2026.
How has IQVIA's derivative assets changed year-over-year?
IQVIA's derivative assets decreased by 100.0% year-over-year, from $3M to $0.
What is the long-term trend for IQVIA's derivative assets?
Over 5 years (2020 to 2025), IQVIA's derivative assets has grown at a -100.0% compound annual growth rate (CAGR), from $5M to $0.
What does derivative assets mean?
Fair value of derivative contracts (swaps, options, forwards, futures) in a net gain position — represents amounts owed to the firm by counterparties.